Jean Coutu Group PJC Inc (TSE:PJC.A)‘s stock had its “reduce” rating reissued by equities researchers at TD Securities in a research note issued on Friday. They currently have a C$17.50 target price on the stock.
Several other equities research analysts have also recently issued reports on the stock. CIBC reissued a “sector perform” rating and issued a C$19.00 target price on shares of Jean Coutu Group PJC in a research report on Wednesday, July 6th. Scotiabank reissued a “sector perform” rating and issued a C$19.00 target price on shares of Jean Coutu Group PJC in a research report on Tuesday, July 5th. Royal Bank Of Canada decreased their target price on shares of Jean Coutu Group PJC from C$20.00 to C$19.00 and set a “sector perform” rating on the stock in a research report on Wednesday, July 6th. Finally, Dundee Securities reissued a “neutral” rating and issued a C$20.00 target price on shares of Jean Coutu Group PJC in a research report on Thursday, September 22nd. One research analyst has rated the stock with a sell rating and six have given a hold rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of C$19.31.
About Jean Coutu Group PJC
The Jean Coutu Group (PJC) Inc is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees.
Receive News & Ratings for Jean Coutu Group PJC Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jean Coutu Group PJC Inc and related companies with MarketBeat.com's FREE daily email newsletter.